Literature DB >> 34157150

Post-9/11 excess risk of thyroid cancer: Surveillance or exposure?

Maaike van Gerwen1,2, Janete M Cerutti3, Joseph Rapp2,4, Eric Genden1, Gregory J Riggins5, Emanuela Taioli2,4,6.   

Abstract

An excess risk of thyroid cancer has been reported in different World Trade Center (WTC)-dust exposed cohorts. Increased surveillance of these cohorts has been suggested as a potential explanation of this reported excess thyroid cancer risk leading to an increased diagnosis of earlier-stage thyroid cancers. However, the uncertainty to what extent surveillance or physician bias may be contributing to the reported incidence of thyroid cancer in WTC-dust exposed populations remains, highlighting the need to investigate a potential causal link between WTC dust exposure and thyroid cancer. Future studies are therefore indicated to investigate potential consequences of WTC dust exposure on the thyroid gland. Studies of the heavily exposed populations offer the possibility to better understand the mechanisms behind the exposure to a variety of environmental contaminants, and may provide useful insights into exposures harmful to the thyroid. These can be used in risk stratification when implementing screening in high-risk populations and may inform shared decision-making regarding the extent of thyroid cancer treatment.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  World Trade Center; carcinogens; contaminants; endocrine disrupting chemicals; environmental exposure; overdiagnosis; surveillance; thyroid cancer

Mesh:

Substances:

Year:  2021        PMID: 34157150     DOI: 10.1002/ajim.23268

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  1 in total

1.  Retrospective analysis of clinical characteristics and risk factors of differentiated thyroid cancer in children.

Authors:  Chun Chen; Lei Hang; Yan Wu; Qing Zhang; Yifei Zhang; Jun Yang; Jin Xie; Jingrong Lu
Journal:  Front Pediatr       Date:  2022-09-12       Impact factor: 3.569

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.